false
Catalog
How to Avoid and Manage CIED Implantation-Related ...
Pocket Hematoma Prevention: Lessons learned from B ...
Pocket Hematoma Prevention: Lessons learned from Bruise Control I and II (Presenter: David H. Birnie, MD)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, the speaker discusses the lessons learned from the Bruise Control 1 and 2 trials regarding pocket hematoma prevention. Hematomas can have negative effects on patients, causing pain and leading to prolonged cessation of anticoagulation. They can also increase the risk of infection, with patients who develop hematomas having a higher risk of infection compared to those without hematomas. The speaker emphasizes that heparin bridging should never be used, as it has been shown to increase the risk of hematoma compared to continued warfarin therapy. When it comes to direct oral anticoagulants (DOACs), the speaker suggests that interruption or continuation of DOAC therapy around device surgery is reasonable, depending on the individual patient's risk for stroke. Finally, the speaker highlights the importance of considering antiplatelet agents, as they have been found to double the rate of clinically significant hematoma. Overall, the speaker provides four main lessons: hematomas are bad for patients, heparin bridging should never be used, DOAC therapy can be interrupted or continued depending on the patient's risk profile, and antiplatelets should also be taken into account in hematoma prevention.
Meta Tag
Lecture ID
7254
Location
Room 155
Presenter
David H. Birnie, MD
Role
Invited Speaker
Session Date and Time
May 10, 2019 4:30 PM - 6:00 PM
Session Number
S-088
Keywords
pocket hematoma prevention
hematomas
infection risk
heparin bridging
DOAC therapy
device surgery
antiplatelet agents
Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy
|
Cookie Declaration
|
Linking Policy
|
Patient Education Disclaimer
|
State Nonprofit Disclosures
|
FAQ
×
Please select your language
1
English